Risk of Dementia in The Patients with Inflammatory Arthritis

In the case of rheumatoid arthritis with a positive serological test, this study also showed a high risk of developing dementia, similar to the results of other previous studies. Regarding changes according to the administration of biological agents, previous studies have shown that anti-TNF antagonists lower the risk of developing dementia, but this study also showed that the administration of biological agents lowers the risk of developing dementia, and anti-TNF antagonists Rather, in the case of non-anti-TNF antagonists, a statistically significant decrease was shown.